During the coming months I shall endeavor to achieve the following milestones:
1) Settle all outstanding convertible notes payable in order that the Company will have no convertible instruments outstanding. 2) Hire a Chief Scientific Officer 3) Seek out and enter into alliances, co-development agreements and additional licensing agreements with regard to our proprietary mRNA and NR2F6 portfolios. 4) Obtain OTCQB listing for our securities on the OTC Market. 5) Establish a social media presence in order to more easily provide updates to our shareholders, the investment community, the scientific community and the public at large.
Market Data 
Markets 
AI
